GLP-1 Therapies: New Direct-to-Employer Models Emerge

“Access” is no longer just a benefit — it’s a strategic lever. As employers face rising demand for GLP‑1 therapies, new direct‑to‑employer models are emerging to reduce complexity and improve outcomes. Deanna Horner shares what’s changing and what it means for the future of care. Read more https://lnkd.in/dXnw5dTA Waltz Health #HealthcareAccess #GLP1 #Commercialization #LifeSciences

To view or add a comment, sign in

Explore content categories